Alpha 2.0
Login Register
» Articles » PMID: 34290882

ABO Phenotype and Clinical Correlates of COVID-19 Severity in Hospitalized Patients

Overview
Journal Future Sci OA
Specialty Biotechnology
Date 2021 Jul 22
PMID 34290882
Citations 7
Authors
David J Hermel
Samantha R Spierling Bagsic
Carrie L Costantini
James R Mason
Zhubin J Gahvari
Alan Saven
Affiliations
Soon will be listed here.
Abstract

Aim: This study investigates the association between ABO blood phenotype and COVID-19 severity, measured by intensive care unit admission, need for intubation, hospitalization length and death. It further explores clinical predictors of COVID-19 severity within a primarily Hispanic demographic in San Diego County.

Materials & Methods: We retrospectively reviewed 942 total patients, 473 with available blood type, hospitalized at five Scripps Health hospitals with COVID-19.

Results: No significant association was found between ABO phenotype and COVID-19 severity on multivariate analysis, while a diagnosis of anemia and male sex was associated with all severity outcomes on exploratory analysis.

Conclusion: Our results provide relevant clinical correlates of COVID-19 severity and help better elucidate the association between ABO phenotype and COVID-19.

Citing Articles

Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study.

Yuan Y, Xu J, Ma B, Chen G, Wang Z, Wang S Front Immunol. 2023; 14:1107866.

PMID: 36936962 PMC: 10020218. DOI: 10.3389/fimmu.2023.1107866.

Correlation between ABO blood type, susceptibility to SARS-CoV-2 infection and COVID-19 disease severity: A systematic review.

Soares D, Araujo D, Souza J, Mauricio R, Soares E, Neto F Hematol Transfus Cell Ther. 2022; 45(4):483-494.

PMID: 36467112 PMC: 9708632. DOI: 10.1016/j.htct.2022.11.001.

A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID-19 susceptibility, severity, and long COVID-19.

Moslemi C, Saekmose S, Larsen R, Brodersen T, Didriksen M, Hjalgrim H Transfusion. 2022; 63(1):47-58.

PMID: 36271437 PMC: 9874484. DOI: 10.1111/trf.17170.

Significant association between anemia and higher risk for COVID-19 mortality: A meta-analysis of adjusted effect estimates.

Wang Y, Nan L, Hu M, Zhang R, Hao Y, Wang Y Am J Emerg Med. 2022; 58:281-285.

PMID: 35753290 PMC: 9217068. DOI: 10.1016/j.ajem.2022.06.030.

The rs8176740 and rs512770 Genetic Variants of the Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets.

Vargas-Alarcon G, Ramirez-Bello J, Posadas-Sanchez R, Rojas-Velasco G, Lopez-Reyes A, Martinez-Gomez L Biomolecules. 2022; 12(4).

PMID: 35454075 PMC: 9027896. DOI: 10.3390/biom12040486.

References
1.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J . Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81(2):e16-e25. PMC: 7177098. DOI: 10.1016/j.jinf.2020.04.021. View
2.
Cooling L . Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev. 2015; 28(3):801-70. PMC: 4475644. DOI: 10.1128/CMR.00109-14. View
3.
Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M . The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020; 5(10). PMC: 7259533. DOI: 10.1172/jci.insight.137799. View
4.
Astle W, Elding H, Jiang T, Allen D, Ruklisa D, Mann A . The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016; 167(5):1415-1429.e19. PMC: 5300907. DOI: 10.1016/j.cell.2016.10.042. View
5.
Latz C, DeCarlo C, Boitano L, Png C, Patell R, Conrad M . Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020; 99(9):2113-2118. PMC: 7354354. DOI: 10.1007/s00277-020-04169-1. View